Templeton Foreign Fund Q1 2025 Commentary
Source: SeekingAlpha
2025-04-30 22:20:00 ET
Summary
- International equities advanced in Q1 2025 despite US economic concerns and trade policy issues, with strong performance in industrials, financials, and energy sectors.
- Alibaba Group was the top stock contributor, benefiting from strong management and growth in e-commerce and cloud businesses, exceeding consensus estimates.
- Stock selection in materials and utilities sectors, and lack of exposure to communication services, detracted from performance; JD Sports Fashion was the top detractor.
- The investment outlook for 2025 is challenging but opportunity-rich, with a focus on thorough fundamental stock research, long-term view, and valuation amid market volatility.
Templeton Foreign Fund as of March 31, 2025 Average annual total returns and fund expenses (%) ...
Read the full article on Seeking Alpha
For further details see:
Templeton Foreign Fund Q1 2025 Commentary
AstraZeneca PLC
NASDAQ: AZN
AZN Trading
9.5% G/L:
$93.12 Last:
2,417,086 Volume:
$93.03 Open:
AZN Latest News
March 10, 2026 08:30:00 am
AstraZeneca and Joshua Jackson partner to encourage fans to Get Body Checked Against Cancer
March 09, 2026 08:05:00 am
Koselugo approved in Canada for plexiform neurofibromas in adults with neurofibromatosis type 1
AZN Stock Data
$606,922,468,616
3,070,437,221
0.1%
781
N/A
Pharmaceuticals
Healthcare
GB
Cambridge
